Back to Search
MARK DUNLAP, MD
MD
Cardiovascular Disease Physician
NPI: 1255342440Individual
Specialties, Licenses & Credentials
Cardiovascular Disease PhysicianPrimary
Internal Medicine — Cardiovascular Disease
Code: 207RC0000X
35-059178(OH)
Research & Publications (20)
New studies influencing treatment of heart failure: 2006 update.
PMID 17381369·Pharmacotherapy·2007
6-review
Mechanisms of altered vagal control in heart failure: influence of muscarinic receptors and acetylcholinesterase activity.
PMID 12829433·Am J Physiol Heart Circ Physiol·2003
7-preclinical
ACE inhibitors vs ARBs: is one class better for heart failure.
PMID 12022388·Cleve Clin J Med·2002
5-case
Incidence of non-AIDS-defining malignancies in HIV-infected versus noninfected patients in the HAART era: impact of immunosuppression.
PMID 19617846·J Acquir Immune Defic Syndr·2009
4-observational
DITPA (3,5-Diiodothyropropionic Acid), a thyroid hormone analog to treat heart failure: phase II trial veterans affairs cooperative study.
PMID 19506112·Circulation·2009
3-trial
Renal hemodynamics in heart failure: implications for treatment.
PMID 18090676·Curr Opin Nephrol Hypertens·2008
6-review
The heart failure clinic: a consensus statement of the Heart Failure Society of America.
PMID 19041043·J Card Fail·2008
6-review
Aortic diameter, wall stiffness, and wave reflection in systolic hypertension.
PMID 18071054·Hypertension·2008
4-observational
Incidence and predictors of hyperkalemia in patients with heart failure: an analysis of the CHARM Program.
PMID 17996561·J Am Coll Cardiol·2007
8-other
Augmentation index and central aortic stiffness in middle-aged to elderly individuals.
PMID 17531921·Am J Hypertens·2007
2-rct
Long-term trandolapril treatment is associated with reduced aortic stiffness: the prevention of events with angiotensin-converting enzyme inhibition hemodynamic substudy.
PMID 17452505·Hypertension·2007
2-rct
Characterization of health-related quality of life in heart failure patients with preserved versus low ejection fraction in CHARM.
PMID 17188020·Eur J Heart Fail·2007
4-observational
Pulsatile hemodynamic effects of candesartan in patients with chronic heart failure: the CHARM Program.
PMID 16188495·Eur J Heart Fail·2006
2-rct
fMRI in alert, behaving monkeys: an adaptation of the human infant familiarization novelty preference procedure.
PMID 16675025·J Neurosci Methods·2006
4-observational
Relationship of dose of background angiotensin-converting enzyme inhibitor to the benefits of candesartan in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM)-Added trial.
PMID 16644319·Am Heart J·2006
8-other
Changes in aortic stiffness and augmentation index after acute converting enzyme or vasopeptidase inhibition.
PMID 16230523·Hypertension·2005
2-rct
Aldosterone antagonists in the treatment and prevention of heart failure.
PMID 16283969·Curr Treat Options Cardiovasc Med·2005
8-other
Combination pharmacologic therapies for heart failure: what next after angiotensin-converting enzyme inhibitors and beta-blockers?
PMID 16036056·Curr Heart Fail Rep·2005
6-review
Treatment of heart failure with a normal ejection fraction.
PMID 16004862·Curr Treat Options Cardiovasc Med·2005
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2500 METROHEALTH DR., METROHEALTH MEDICAL CENTER
CLEVELAND, OH 44113 - Phone
- (216) 780-1766
Quick Facts
- NPI
- 1255342440
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile